ArticleBMC public health2025
Colorectal cancer screening blood test: awareness and willingness among a national sample of adults post-Federal and Drug Administration approval.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging trends in the global burden of colorectal cancer.Nature reviews. Clinical oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo assess awareness and willingness of average-risk adults to complete a colorectal cancer (CRC) screening blood test and evaluate test preferences for future screening.
methodsFollowing approval by the United States Food and Drug Administration, a cross-sectional online survey was conducted in September 2024 of adults ages 45-75 in the United States (n = 633). An informative statement about the new test was followed by a series of questions. Logistic regression identified correlates of participants' willingness to complete a CRC screening blood test.
resultsOnly 18.2% of participants were aware of a CRC screening blood test. Most (77.9%) were willing to get the test if free or covered by health insurance, while only 19.2% were willing if it cost $895 out of pocket. Participants were more willing to complete a free CRC screening blood test if they had a high household income (odds ratio [OR] = 5.12, 95% confidence interval [CI]: 1.63-16.13), had a routine medical check-up in the last year (OR = 2.87, CI:1.44-5.71), and were more wanting to talk to a doctor at their next medical appointment about the new test (OR = 2.55, CI: 1.92-3.37). Participants' preferred CRC screening approach for the future was the blood test every three years (53.0%), an annual stool test (31.1%), and a colonoscopy every 10 years (15.8%).
conclusionsThe blood test has the potential to increase CRC screening, as most participants were willing to complete the test if it was free or covered by health insurance. Findings can guide the development of programs that include the CRC screening blood test as an option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.